Search Result "antirheumaticdrugs"
Functional Components from Nature-Derived Drugs for the Treatment of Rheumatoid Arthritis
Journal: Current Drug Targets
Volume: 17 Issue: 1 Year: 2016 Page: 1673-1686
Author(s): Qin Ma, Jian-Guo Jiang
Lipid-based Vesicular Nanocargoes as Nanotherapeutic Targets for the Effective Management of Rheumatoid Arthritis
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 11 Issue: 1 Year: 2016 Page: 3-15
Author(s): Mahfoozur Rahman,Sarwar Beg,Gajanand Sharma,Sumant Saini,Rehan A. Rub,Preeti Aneja,Firoz Anwar,Mohammad A. Alam,Vikas Kumar
Association of Autoimmune Disorders and Disease-modifyingAntirheumatic Drugs: (DMARDs) with the Risk of Alzheimerâs and/orDementia: A Population Study Using Medicare Beneficiary Data
Journal: Current Alzheimer Research
Volume: 20 Issue: 10 Year: 2023 Page: 725-737
Author(s): Alison M. Konieczny,Tyler B. Bringedahl,Kiara Y. Torres Garcia
Nano - Based Therapeutic Strategies in Management of RheumatoidArthritis
Journal: Recent Patents on Nanotechnology
Volume: 18 Issue: 4 Year: 2024 Page: 433-456
Author(s): Shiv Kant Sharma
Medication Adherence of Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis Considering the Psychosocial Factors, Health Literacy and Current Life Concerns of Patients
Journal: Current Rheumatology Reviews
Volume: 17 Issue: 4 Year: 2021 Page: 412-420
Author(s): Saeedeh Shenavandeh,Arash Mani,Mehdi Eazadnegahdar,Ali Nekooeian
Effects of Hydroxychloroquine on Progression of Diabetic Retinopathy inSubjects with Rheumatoid Arthritis and Type 2 Diabetes Mellitus
Journal: Current Diabetes Reviews
Volume: 18 Issue: 9 Year: 2022 Page: 102-107
Author(s):
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in theFirst Three Pandemic Waves. Relationship with Disease Subgroups and OngoingTherapies
Journal: Current Pharmaceutical Design
Volume: 28 Issue: 24 Year: 2022 Page: 2022-2028
Author(s): Ylenia Dal Bosco,Giuseppa Pagano Mariano,Sabrina Rosaria Paparo,Silvia Martina Ferrari,Maria Letizia Aprile,Anna Linda Zignego
Medicolegal Aspects of Disclosure of Side Effects of Biologic Drugs in Rheumatology: A Pilot Study
Journal: New Emirates Medical Journal
Volume: 2 Issue: 1 Year: 2021 Page: 25-30
Author(s): Ryan Basheer,Souheil Moufarrej,Humeira Badsha
Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target?
Journal: Current Vascular Pharmacology
Volume: 18 Issue: 5 Year: 2020 Page: 425-430
Author(s): Antonis S. Manolis,Athanasios G. Tzioufas
Pharmacokinetics of Anti-rheumatic Drugs Methotrexate andTofacitinib with its Metabolite M9 in Rats by UPLC-MS/MS
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 22 Year: 2024 Page: 3426-3435
Author(s):